Cargando…
Neuraminidase-specific antibody responses are generated in naive and vaccinated newborn nonhuman primates following virus infection
Individuals younger than 6 months of age are at significant risk from influenza virus infection; however, there is currently no vaccine approved for this age group. Influenza virus neuraminidase (NA) has emerged as a potential additional target for vaccine strategies. In this study, we sought to und...
Autores principales: | Shultz, Patrick K., Crofts, Kali F., Holbrook, Beth C., Alexander-Miller, Martha A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819742/ https://www.ncbi.nlm.nih.gov/pubmed/33264104 http://dx.doi.org/10.1172/jci.insight.141655 |
Ejemplares similares
-
Analysis of R848 as an Adjuvant to Improve Inactivated Influenza Vaccine Immunogenicity in Elderly Nonhuman Primates
por: Crofts, Kali F., et al.
Publicado: (2022) -
Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination
por: Crofts, Kali F., et al.
Publicado: (2020) -
Use of Nonhuman Primate Models to Develop Mucosal AIDS Vaccines
por: Genescà, Meritxell, et al.
Publicado: (2010) -
The Use of Nonhuman Primate Models in HIV Vaccine Development
por: Morgan, Cecilia, et al.
Publicado: (2008) -
Vaccine delivery with microneedle skin patches in nonhuman primates
por: DeMuth, Peter C., et al.
Publicado: (2013)